Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Hormone Molecular Biology and Clinical Investigation is Scopus-indexed (Q3, CiteScore 3.6), WoS ESCI. Published by Walter de Gruyter GmbH.
Checked against the index lists dated .
ISSN 1868-1883Verify ISSN ↗1868-1891Verify ISSN ↗
Publisher: Walter de Gruyter GmbH
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Endocrinology, Diabetes and Metabolism | 147 / 250 | 41st | Q3 |
| Endocrinology | 91 / 132 | 31st | Q3 |
| Molecular Biology | 294 / 414 | 29th | Q3 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2010–present, best quartile Q3, CiteScore 3.6.
Hormone Molecular Biology and Clinical Investigation is Q3 in Endocrinology, Diabetes and Metabolism (rank 147 of 250), Q3 in Endocrinology (rank 91 of 132) and Q3 in Molecular Biology (rank 294 of 414), by CiteScore 2025.
Hormone Molecular Biology and Clinical Investigation is indexed in the Emerging Sources Citation Index, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 3.6, which places it in quartile Q3 at the 41st percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.458, quartile Q3, with an H-index of 48.
No article processing charge is recorded for it (source: OpenAlex). Confirm on the journal's own website, since some journals charge for extras such as colour figures.
Hormone Molecular Biology and Clinical Investigation is published by Walter de Gruyter GmbH. Its print ISSN is 1868-1883 and its online ISSN is 1868-1891.
Yes — indexed in the Emerging Sources Citation Index.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Hormone Molecular Biology and Clinical Investigation has an h-index of 53 and a 2-year mean of 1.97 citations per paper (OpenAlex). Its Scopus CiteScore is 3.6, quartile Q3. On 2-year citations it ranks #135 of 246 Scopus journals in Endocrinology, Diabetes and Metabolism.
Hormone Molecular Biology and Clinical Investigation published 21 papers in 2025; its busiest recent year was 2021 with 85. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 100 research articles (2022–2026), authors are most often from Iran (36.5%), India (25%) and Iraq (4.8%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 2 retracted papers are recorded (2.1 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.